Riskpilot← Back to searchSign inGet full accessDirilis Invest AB
ABActiveOrg 5568654437Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20110 employees
Revenue 2024
SEK -4
-100% vs 2023
EBITDA margin
1437700.0%
-129% vs 2023
Equity ratio
68.1%
Financial strength
Net profit 2024
SEK -57K
-124% vs 2023
| Revenue | SEK -4 | -100% |
| EBITDA | SEK -58K | -129% |
| Net profit | SEK -57K | -124% |
| Total assets | SEK 116K | -69% |
| Equity | SEK 79K | -77% |
| Employees | 0 | — |
Legal name
Dirilis Invest AB
Org number
5568654437
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23 september 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska driva konsultverksamhet och rådgivning inom bemanning form. Handel med ädelmetaller som guld, silver med mera. Handel med ädelstenar som diamanter, briljanter med mera. Handel med elektronik som datorer, telefoner med mera. Handel med aktier, valutor samt handel med värdepapper. Bemanningsverksamhet. Restaurant och kaféverksamhet. Import och export av textil, grönsaker och elektronik.
Address
Phone
+4686581100
Email
amet.k.goel@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 164 | 361 | −0 | 227 | −0 |
| Staff expenses | — | — | −32 | −0 | −33 |
| EBITDA | −105 | −15 | −75 | 202 | −58 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −105 | −15 | −75 | 202 | −58 |
| Net financials | −133 | −47 | −67 | 64 | 0 |
| Profit before tax | −202 | 46 | −142 | 265 | −57 |
| Tax | −167 | −10 | — | −25 | — |
| Net profit | −369 | 36 | −142 | 240 | −57 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 486 | 416 | 272 | 372 | 116 |
| Equity | 395 | 430 | 101 | 341 | 79 |
| Long-term debt | 0 | 0 | 9 | 3 | 0 |
| Short-term debt | 15 | 15 | 162 | 28 | 37 |
| Total debt | 15 | 15 | 172 | 31 | 37 |
EBITDA margin
-5750800.0%
This company
15.8%
Market median
-36397568% vs market
20202024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20202024
Return on equity
-72.7%
This company
18.4%
Market median
-495% vs market
20202024
Net profit margin
-5738900.0%
This company
8.1%
Market median
-70850717% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dirilis Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ahmet Kücükgöl | Board of Directors | 0 companies |
| Cengiz Kücükgöl | Deputy Board Member | 0 companies |